Interestingly, NF-κB, metalloproteinases (MMPs), and NOTCH alterations have been described in CRC, further contributing to treatment failure associated with chemo-resistance (Zheng et al., 2015). The gene discussed is NFKB1; the disease is colorectal carcinoma.